<?xml version="1.0" encoding="UTF-8"?>
<rss  xmlns:atom="http://www.w3.org/2005/Atom" 
      xmlns:media="http://search.yahoo.com/mrss/" 
      xmlns:content="http://purl.org/rss/1.0/modules/content/" 
      xmlns:dc="http://purl.org/dc/elements/1.1/" 
      version="2.0">
<channel>
<title>Society of Cutaneous Oncology</title>
<link>https://cutaneousoncology.io/presentations.html</link>
<atom:link href="https://cutaneousoncology.io/presentations.xml" rel="self" type="application/rss+xml"/>
<description></description>
<generator>quarto-1.3.450</generator>
<lastBuildDate>Sat, 01 Apr 2023 13:45:00 GMT</lastBuildDate>
<item>
  <title>Integrating Novel Treatment Approaches for Cutaneous Squamous Cell Carcinoma</title>
  <dc:creator>David M. Miller</dc:creator>
  <link>https://cutaneousoncology.io/presentations/RME_Collaborative_2023/CSCC/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>RME Collaborative Oncology Congress</p>
</section>
<section id="overview-learning-objectives" class="level1">
<h1>Overview &amp; Learning Objectives</h1>
<ul>
<li>Summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for cutaneous squamous cell carcinoma (CSCC)</li>
<li>Develop individualized management plans for advanced and metastatic CSCC, incorporating current guideline recommendations, clinical data, and best practices</li>
<li>Implement evidence-based strategies for reducing disparities in CSCC care and treatment in rural and underserved settings</li>
</ul>


</section>

 ]]></description>
  <category>2023</category>
  <category>Oncology Congress</category>
  <category>CSCC</category>
  <guid>https://cutaneousoncology.io/presentations/RME_Collaborative_2023/CSCC/index.html</guid>
  <pubDate>Sat, 01 Apr 2023 13:45:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/RME_Collaborative_2023/CSCC/DMM_pic_cropped.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Novel Approaches to RAS Targeting</title>
  <dc:creator>Ryan J. Sullivan</dc:creator>
  <link>https://cutaneousoncology.io/presentations/MCGI_2023/novel_approaches_to_ras_targeting/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>2023 MCGI Forum</p>
</section>
<section id="overview-learning-objectives" class="level1">
<h1>Overview &amp; Learning Objectives</h1>
<ul>
<li>Discussion of novel approaches to targeting RAS</li>
</ul>


</section>

 ]]></description>
  <category>2023</category>
  <category>MCGI</category>
  <guid>https://cutaneousoncology.io/presentations/MCGI_2023/novel_approaches_to_ras_targeting/index.html</guid>
  <pubDate>Sat, 01 Apr 2023 11:20:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/MCGI_2023/novel_approaches_to_ras_targeting/ryan_sullivan.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Integrating the Latest Evidence on Management of Basal Cell Carcinoma</title>
  <dc:creator>David M. Miller</dc:creator>
  <link>https://cutaneousoncology.io/presentations/RME_Collaborative_2023/BCC/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>RME Collaborative Oncology Congress</p>
</section>
<section id="overview-learning-objectives" class="level1">
<h1>Overview &amp; Learning Objectives</h1>
<ul>
<li>Implement evidence-based strategies for reducing disparities in basal cell carcinoma (BCC) care in rural and underserved settings</li>
<li>Differentiate treatment options for BCC based on clinical efficacy and safety data</li>
<li>Integrate clinical evidence and current guideline recommendations into treatment plans for patients with BCC</li>
<li>Recognize adverse events associated with therapies for BCC to improve adherence to therapy</li>
</ul>


</section>

 ]]></description>
  <category>2023</category>
  <category>Oncology Congress</category>
  <category>BCC</category>
  <guid>https://cutaneousoncology.io/presentations/RME_Collaborative_2023/BCC/index.html</guid>
  <pubDate>Fri, 31 Mar 2023 16:00:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/RME_Collaborative_2023/BCC/DMM_pic_cropped.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Intralesional Treatments for Cancer</title>
  <dc:creator>Howard L Kaufman</dc:creator>
  <link>https://cutaneousoncology.io/presentations/SSO_2023/Intralesional_Treatments_for_Cancer/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>Society of Surgical Oncology International Conference on Surgical Cancer Care Meeting “The Evolution of Novel Combination Immunotherapies – Intralesional Treatments and New Targets for Treatment” Session</p>


</section>

 ]]></description>
  <category>2023</category>
  <category>SSO</category>
  <guid>https://cutaneousoncology.io/presentations/SSO_2023/Intralesional_Treatments_for_Cancer/index.html</guid>
  <pubDate>Thu, 23 Mar 2023 16:45:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/SSO_2023/Intralesional_Treatments_for_Cancer/Howard Kaufman.jpeg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Respect the Dormant Beast: Optimize Your Management of High-risk Cutaneous SCCs</title>
  <dc:creator>Vishal A. Patel</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/optimize_your_management_of_high-risk_cutaneous_SCCs/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>American Academy of Dermatology Annual Meeting “Respect the Dormant Beast: Optimize Your Management of High-risk Cutaneous SCCs” Session</p>


</section>

 ]]></description>
  <category>2023</category>
  <category>AAD Meeting</category>
  <category>CSCC</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/optimize_your_management_of_high-risk_cutaneous_SCCs/index.html</guid>
  <pubDate>Mon, 20 Mar 2023 15:30:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/optimize_your_management_of_high-risk_cutaneous_SCCs/VAP Headshot New.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Volunteering Abroad, A Surgical Perspective</title>
  <dc:creator>Vishal A. Patel</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/volunteering_abroad_a_surgical_perspective/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>American Academy of Dermatology Annual Meeting “Volunteers Abroad: Beginners” Session</p>


</section>

 ]]></description>
  <category>2023</category>
  <category>AAD Meeting</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/volunteering_abroad_a_surgical_perspective/index.html</guid>
  <pubDate>Mon, 20 Mar 2023 14:20:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/volunteering_abroad_a_surgical_perspective/VAP Headshot New.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Exploring Neoadjuvant Immunotherapies for Surgically Resectable Cutaneous Squamous Cell Carcinoma</title>
  <dc:creator>David M. Miller</dc:creator>
  <dc:creator>Vishal A. Patel</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/exploring_neoadjuvant_immunotherapies_for_resectable_CSCC/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level2">
<h2 class="anchored" data-anchor-id="event">Event</h2>
<p>Med Learning Group TeleECHO. <a href="https://d.answersincme.com/160202423_1/160202423_1_p1/stage1reg?SpecialtyID=&amp;ProfessionID=&amp;Promocode=310&amp;CampaignID=1730844323&amp;CountryID=US&amp;AudienceID=AICME&amp;ProjectNumber=160202423_1">Event URL</a></p>
</section>
<section id="overview" class="level2">
<h2 class="anchored" data-anchor-id="overview">Overview</h2>
<p>In this live program we discuss how neoadjuvant immunotherapy fits into the treatment plan for many patients with surgically resectable cutaneous squamous cell carcinoma.</p>


</section>

 ]]></description>
  <category>2023</category>
  <category>CSCC</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/exploring_neoadjuvant_immunotherapies_for_resectable_CSCC/index.html</guid>
  <pubDate>Sun, 19 Mar 2023 19:00:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/exploring_neoadjuvant_immunotherapies_for_resectable_CSCC/featured.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>A non-invasive, adhesive patch gene expression test is safe and cost effective for melanoma screening: CON?</title>
  <dc:creator>Laura K Ferris</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/a_non-invasive_adhesive_patch_gene_expression_test_is_safe_and_cost_effective_for_melanoma_screening/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>American Academy of Dermatology Annual Meeting “The 2023 Debates: Controversies in Dermatology” Session</p>


</section>

 ]]></description>
  <category>2023</category>
  <category>AAD Meeting</category>
  <category>Melanoma</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/a_non-invasive_adhesive_patch_gene_expression_test_is_safe_and_cost_effective_for_melanoma_screening/index.html</guid>
  <pubDate>Sun, 19 Mar 2023 13:41:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/a_non-invasive_adhesive_patch_gene_expression_test_is_safe_and_cost_effective_for_melanoma_screening/ferris_laura.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Multidisciplinary Management of Melanoma and Merkel Cell Carcinoma</title>
  <dc:creator>Vishal A. Patel</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/multidisciplinary_management_of_melanoma_and_mcc/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>American Academy of Dermatology Annual Meeting “Pearls from Complex Mohs” Session</p>


</section>

 ]]></description>
  <category>2023</category>
  <category>AAD Meeting</category>
  <category>Melanoma</category>
  <category>Merkel Cell Carcinoma</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/multidisciplinary_management_of_melanoma_and_mcc/index.html</guid>
  <pubDate>Sat, 18 Mar 2023 16:30:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/multidisciplinary_management_of_melanoma_and_mcc/VAP Headshot New.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Update on the Latest Advances in Treatment of Melanoma</title>
  <dc:creator>Vernon Sondak</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/update_on_the_latest_advances_in_treatment_of_melanoma/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>American Academy of Dermatology Annual Meeting “Updates in Cutaneous Oncology” Session</p>


</section>

 ]]></description>
  <category>2023</category>
  <category>AAD Meeting</category>
  <category>Melanoma</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/update_on_the_latest_advances_in_treatment_of_melanoma/index.html</guid>
  <pubDate>Sat, 18 Mar 2023 14:55:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/update_on_the_latest_advances_in_treatment_of_melanoma/SondakVernon_2995.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Updates in Merkel Cell Carcinoma</title>
  <dc:creator>David M. Miller</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/updates_in_mcc/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>American Academy of Dermatology Annual Meeting “Updates in Cutaneous Oncology” Session</p>
</section>
<section id="overview-learning-objectives" class="level1">
<h1>Overview &amp; Learning Objectives</h1>
<ul>
<li>Brief overview of pathophysiology of Merkel cell carcinoma<br>
</li>
<li>Recognize the use of Imaging and the Merkel cell polyoma virus serum antibody test in clinical practice<br>
</li>
<li>Discuss recently approved therapeutic strategies in MCC, including the use of Immune Checkpoint Inhibitors as primary treatment, as well as emerging strategies in the neo-adjuvant and adjuvant setting</li>
</ul>
</section>
<section id="presentation-slides" class="level1">
<h1>Presentation Slides</h1>
<ul>
<li>To view the slides for this presentation, please click <a href="https://cutaneousoncology.io/slides/aad_annual_meeting_2023/updates_in_mcc/#/section">here</a></li>
</ul>


</section>

 ]]></description>
  <category>2023</category>
  <category>AAD Meeting</category>
  <category>Merkel Cell Carcinoma</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/updates_in_mcc/index.html</guid>
  <pubDate>Sat, 18 Mar 2023 13:30:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/updates_in_mcc/DMM_pic_cropped.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Management of High Risk Uncommon Cutaneous Neoplasms</title>
  <dc:creator>David M. Miller</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/management_of_high_risk_uncommon_cutaneous_neoplasms/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>American Academy of Dermatology Annual Meeting “What’s New in the Management of Advanced Skin Cancer” Session</p>
</section>
<section id="overview-learning-objectives" class="level1">
<h1>Overview &amp; Learning Objectives</h1>
<ul>
<li>Brief overview of pathophysiology of Sebaceous Carcinoma, Dermatofibrosarcoma Protuberans and Merkel cell carcinoma<br>
</li>
<li>Recognize the use of Imaging and the Merkel cell polyoma virus serum antibody test in clinical practice<br>
</li>
<li>Discuss recently approved therapeutic strategies in MCC, including the use of Immune Checkpoint Inhibitors as primary treatment, as well as emerging strategies in the neo-adjuvant and adjuvant setting</li>
</ul>
</section>
<section id="presentation-slides" class="level1">
<h1>Presentation Slides</h1>
<ul>
<li>To view the slides for this presentation, please click <a href="https://cutaneousoncology.io/slides/aad_annual_meeting_2023/management_of_high_risk_uncommon_cutaneous_neoplasms/">here</a></li>
</ul>
<div style="background-color:#F5F5F5; margin-left: 0px; padding: 0px; padding-left: 0px; font-size: 12px">
Tis site represents our opinions only. See our full <a href="ttps://www.temillerlab.io/privacy/">Disclaimer</a> and <a href="ttps://www.temillerlab.io/terms/">Terms of Use Agreement</a>
</div>


</section>

 ]]></description>
  <category>2023</category>
  <category>AAD Meeting</category>
  <category>Merkel Cell Carcinoma</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/management_of_high_risk_uncommon_cutaneous_neoplasms/index.html</guid>
  <pubDate>Fri, 17 Mar 2023 16:25:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/management_of_high_risk_uncommon_cutaneous_neoplasms/DMM_pic_cropped.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Management of Operable Advanced NMSC</title>
  <dc:creator>David M. Miller</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/management_of_operable_advanced_NMSC/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>American Academy of Dermatology Annual Meeting “What’s New in the Management of Advanced Skin Cancer” Session</p>
</section>
<section id="overview-learning-objectives" class="level1">
<h1>Overview &amp; Learning Objectives</h1>
<ul>
<li>Review the work up for operable NMSC
<ul>
<li>Discuss the utility of SLNBx &amp; imaging in CSCC</li>
<li>Discuss the role of GEP in CSCC</li>
</ul></li>
<li>Review the management of operable NMSC
<ul>
<li>Discuss the role of CPEMA and adjuvant therapy</li>
<li>Discuss the role of pre-operative systemic therapy for NMSC</li>
</ul></li>
</ul>
</section>
<section id="presentations-slides" class="level1">
<h1>Presentations Slides</h1>
<ul>
<li>To view the slides for this presentation, please click <a href="https://cutaneousoncology.io/slides/aad_annual_meeting_2023/management_of_operable_advanced_nmsc/#/section">here</a></li>
</ul>


</section>

 ]]></description>
  <category>2023</category>
  <category>AAD Meeting</category>
  <category>BCC</category>
  <category>CSCC</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/management_of_operable_advanced_NMSC/index.html</guid>
  <pubDate>Fri, 17 Mar 2023 16:00:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/management_of_operable_advanced_NMSC/DMM_pic_cropped.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Update in Advanced Melanoma Therapy</title>
  <dc:creator>Laura Ferris</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/update_in_advanced_melanoma_therapy/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>American Academy of Dermatology Annual Meeting “What’s New in the Management of Advanced Skin Cancer” Session</p>


</section>

 ]]></description>
  <category>2023</category>
  <category>AAD Meeting</category>
  <category>Melanoma</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/update_in_advanced_melanoma_therapy/index.html</guid>
  <pubDate>Fri, 17 Mar 2023 15:35:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/update_in_advanced_melanoma_therapy/ferris_laura.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>Lessons learned from resident selection and recruitment</title>
  <dc:creator>Mayra Lorenzo MD, PhD, FAAD</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/lessons_learned_from_resident_selection_and_recruitment/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>American Academy of Dermatology Annual Meeting “DEI in GME: Thoughts and Considerations” Session</p>


</section>

 ]]></description>
  <category>2023</category>
  <category>AAD Meeting</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/lessons_learned_from_resident_selection_and_recruitment/index.html</guid>
  <pubDate>Fri, 17 Mar 2023 13:00:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/lessons_learned_from_resident_selection_and_recruitment/mayra.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>How do we implement systemic therapy to reduce recurrence of high-risk melanomas: from neoadjuvant to adjuvant therapy?</title>
  <dc:creator>David M. Miller</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/perioperative_systemic_therapy_for_melanoma/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>American Academy of Dermatology Annual Meeting “Managing Melanoma” Session</p>
</section>
<section id="overview-learning-objectives" class="level1">
<h1>Overview &amp; Learning Objectives</h1>
<ul>
<li>Review the work up for high-risk melanoma</li>
<li>Review the role of pre-operative systemic therapy in melanoma</li>
<li>Review the role of post-operative systemic therapy in melanoma</li>
</ul>
</section>
<section id="presentation-slides" class="level1">
<h1>Presentation Slides</h1>
<ul>
<li>To view the slides for this presentation, please click <a href="https://cutaneousoncology.io/slides/aad_annual_meeting_2023/perioperative_systemic_therapy_for_melanoma/#/section">here</a></li>
</ul>
<div style="background-color:#F5F5F5; margin-left: 0px; padding: 0px; padding-left: 0px; font-size: 12px">
Tis site represents our opinions only. See our full <a href="ttps://www.temillerlab.io/privacy/">Disclaimer</a> and <a href="ttps://www.temillerlab.io/terms/">Terms of Use Agreement</a>
</div>


</section>

 ]]></description>
  <category>2023</category>
  <category>AAD Meeting</category>
  <category>Melanoma</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/perioperative_systemic_therapy_for_melanoma/index.html</guid>
  <pubDate>Fri, 17 Mar 2023 10:30:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/perioperative_systemic_therapy_for_melanoma/DMM_pic_cropped.jpg" medium="image" type="image/jpeg"/>
</item>
<item>
  <title>How can we improve detection and reduce unnecessary biopsies: from dermoscopy to artificial intelligence to non-invasive molecular testing?</title>
  <dc:creator>Laura K Ferris</dc:creator>
  <link>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/how_can_we_improve_detection_and_reduce_unnecessary_biopsies_in_melanoma/index.html</link>
  <description><![CDATA[ 



<section id="event" class="level1">
<h1>Event</h1>
<p>American Academy of Dermatology Annual Meeting “Managing Melanoma” Session</p>


</section>

 ]]></description>
  <category>2023</category>
  <category>AAD Meeting</category>
  <category>Melanoma</category>
  <guid>https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/how_can_we_improve_detection_and_reduce_unnecessary_biopsies_in_melanoma/index.html</guid>
  <pubDate>Fri, 17 Mar 2023 09:05:00 GMT</pubDate>
  <media:content url="https://cutaneousoncology.io/presentations/AAD_Annual_Meeting_2023/how_can_we_improve_detection_and_reduce_unnecessary_biopsies_in_melanoma/ferris_laura.jpg" medium="image" type="image/jpeg"/>
</item>
</channel>
</rss>
